null

SMILES: Clc1ccc(cc1)C1=NN(CC1c1ccccc1)C(=N\S(=O)(=O)c1ccc(Cl)cc1)\C(=N)c1ccc(Br)cc1

InChI Key: InChIKey=ORYSBPPSHNFGCU-PCJQJBIFSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 463802   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cannabinoid receptor 1 (Mus musculus (Mouse))	BDBM463802 (US10787419, Serial # 14 | US10787419, Serial # 20) Show SMILES Clc1ccc(cc1)C1=NN(CC1c1ccccc1)C(=N\S(=O)(=O)c1ccc(Cl)cc1)\C(=N)c1ccc(Br)cc1 |t:8| Show InChI InChI=1S/C29H21BrCl2N4O2S/c30-22-10-6-20(7-11-22)27(33)29(35-39(37,38)25-16-14-24(32)15-17-25)36-18-26(19-4-2-1-3-5-19)28(34-36)21-8-12-23(31)13-9-21/h1-17,26,33H,18H2/b33-27?,35-29+	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	27	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
The United States of America, as represented by the Secretary, Department of Health and Human Services US Patent					Assay Description Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...				US Patent US10787419 (2020) BindingDB Entry DOI: 10.7270/Q2HH6P4S
					More data for this Ligand-Target Pair
Cannabinoid receptor 1 (Mus musculus (Mouse))	BDBM463802 (US10787419, Serial # 14 | US10787419, Serial # 20) Show SMILES Clc1ccc(cc1)C1=NN(CC1c1ccccc1)C(=N\S(=O)(=O)c1ccc(Cl)cc1)\C(=N)c1ccc(Br)cc1 |t:8| Show InChI InChI=1S/C29H21BrCl2N4O2S/c30-22-10-6-20(7-11-22)27(33)29(35-39(37,38)25-16-14-24(32)15-17-25)36-18-26(19-4-2-1-3-5-19)28(34-36)21-8-12-23(31)13-9-21/h1-17,26,33H,18H2/b33-27?,35-29+	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	56	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
The United States of America, as represented by the Secretary, Department of Health and Human Services US Patent					Assay Description Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...				US Patent US10787419 (2020) BindingDB Entry DOI: 10.7270/Q2HH6P4S
					More data for this Ligand-Target Pair